BRIEF-Orexigen Therapeutics announces expansion of distributorship agreement with Biologix FZCO for Contrave to Egypt
July 26, 2017 at 09:16 AM EDT
* Orexigen Therapeutics announces expansion of distributorship agreement with Biologix FZCO for Contrave® (naltrexone hcl / bupropion hcl extended release) to Egypt